Hundreds sue GLP-1 makers, alleging rare permanent vision loss
More than 200 federal lawsuits claim GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound caused NAION, a rare form of permanent vision loss, while manufacturers deny the allegations.
In recent years, GLP-1 medications such as Ozempic, Wegovy, Mounjaro and Zepbound have dominated headlines for helping people lose weight — but now those same drugs are making headlines for a different reason.